Editor's Special Invited Paper: Second-Guessing Clinical Trial Designs

REFERENCES

• Barber , S. and Jennison , C. ( 2002 ). Optimal Asymmetric One-Sided Group Sequential Tests, Biometrika 89 : 49 – 60 .
   Web of Science ®Google Scholar
• Chang , M. N. ( 1988 ). Optimal Designs for Group Sequential Clinical Trials, Technical Report 295, Department of Statistics , Gainesville : University of Florida .
   Google Scholar
• Chang , M. N. ( 1996 ). Optimal Designs for Group Sequential Clinical Trials, Communications in Statistics—Theory & Methods 25 : 361 – 379 .
   Web of Science ®Google Scholar
• Eales , J. D. and Jennison , C. ( 1992 ). An Improved Method for Deriving Optimal One-Sided Group Sequential Tests, Biometrika 79 : 13 – 24 .
   Web of Science ®Google Scholar
• Eales , J. D. and Jennison , C. ( 1995 ). Optimal Two-Sided Group Sequential Tests, Sequential Analysis 14 : 273 – 286 .
   Google Scholar
• Ellenberg , S. S. ( 2003 ). Are All Monitoring Boundaries Equally Ethical? Controlled Clinical Trials 24 : 585 – 588 .
   PubMedGoogle Scholar
• Enas , G. G. , Dornseif , B. E. , Sampson , C. B. , Rockhold , F. W. , and Wuu , J. ( 1989 ). Monitoring vs. Interim Analysis of Clinical Trials: A Perspective from the Pharmaceutical Industry, Controlled Clinical Trials 10 : 57 – 70 .
   PubMedGoogle Scholar
• Fleming , T. R. and DeMets , D. L. ( 1993 ). Monitoring of Clinical Trials: Issues and Recommendations, Controlled Clinical Trials 14 : 183 – 197 .
   PubMedGoogle Scholar
• Geller , N. L. and Pocock , S. J. ( 1987 ). Interim Analysis in Randomization Trials: Ramifications and Guidelines for Practitioners, Biometrics 43 : 213 – 223 .
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative Group . ( 2002 ). MRC/BHF Heart Protection Study of Cholesterol-Lowering with Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial, Lancet 360 : 7 – 22 .
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization . ( 1998 ). Guidance on Statistical Principles for Clinical Trials, Federal Register 63 ( 179 ): 49583 – 49598 .
   PubMedGoogle Scholar
• International Sudden Infarct Study #2 Steering Committee . ( 1987 ). Intravenous Streptokinase within 0–4 Hours of Onset of Myocardial Infarction Reduced Mortality, Lancet 1 : 502 .
   PubMed Web of Science ®Google Scholar
• International Sudden Infarct Study #2 Collaborative Group . ( 1988 ). Randomised Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither among 17,187 Cases of Acute Myocardial Infarction: ISIS 2, Lancet 2 : 349 – 360 .
   PubMed Web of Science ®Google Scholar
• Jones , D. and Whitehead , J. ( 1979 ). Sequential Forms of the Log Rank and Modified Wilcoxon Tests for Censored Data, Biometrika (66): 105–114. Corrections, Biometrika 68 : 576 .
   Google Scholar
• Kiefer , J. and Weiss , L. ( 1957 ). Some Properties of Generalized Sequential Probability Ratio Tests, Annals of Mathematical Statistics 28 : 57 – 74 .
   Google Scholar
• Lehmann , E. L. ( 1997 ). Testing Statistical Hypotheses , New York : Springer-Verlag .
   Google Scholar
• Lilford , R. J. , Braunholtz , Z. , Edwards , S. , and Stevens , A. ( 2001 ). Monitoring Clinical Trials—Interim Results Should Be Publicly Available, British Medical Journal 323 : 441 – 442 .
   PubMed Web of Science ®Google Scholar
• Migrino , R. Q. and Topol , E. J. ( 2003 ). A Matter of Life and Death? The Heart Protection Study and Protection of Clinical Trial Participants, Controlled Clinical Trials 24 : 501–505.
   PubMedGoogle Scholar
• O'Brien , P. C. and Fleming , T. R. ( 1979 ). A Multiple Testing Procedure for Clinical Trials, Biometrics 35 : 549 – 556 .
   PubMed Web of Science ®Google Scholar
• Pharmaceuticals Manufacturing Association Biostatistics and Medical Ad Hoc Committee on Interim Analysis. (1993). Interim Analysis in the Pharmaceutical Industry, Controlled Clinical Trials 14: 160–173.
   PubMedGoogle Scholar
• Pocock , S. J. ( 1977 ). Group Sequential Methods in the Design and Analysis of Clinical Trials, Biometrika 64 : 191 – 199 .
   Web of Science ®Google Scholar
• Pocock , S. J. ( 1982 ). Interim Analysis for Randomized Clinical Trials: The Group Sequential Approach, Biometrics 38 : 153 – 162 .
   PubMed Web of Science ®Google Scholar
• Reidpath , D. ( 2001 ). Interim Data Are at Least as Important as Interim Analyses, British Medical Journal 323 : 1425 .
   PubMedGoogle Scholar
• Rosner , G. L. and Tsiatis , A. A. ( 1989 ). The Impact That Group Sequential Tests Would Have Made on ECOG Clinical Trials, Statistics in Medicine 18 : 505 – 516 .
   Google Scholar
• Senchaudhuri , P. , Mehta , C. R. , Deshmukh , A. , Kulthe S. , Ghanekar , A. , Kannappan A. , Khandelwal , L. , and Sathe , A. ( 2005 ). Early Stopping in Clinical Trials (East 4.0) , Cambridge : Cytel Statistical Software .
   Google Scholar
• Shuster , J. J. ( 1992 ). Practical Handbook of Sample Sizes for Clinical Trials , Boca Raton : CRC Press .
   Google Scholar
• Shuster , J. J. , Link , M. , Camitta , B. , Pullen , J. , and Behm , F. ( 2002 ). Minimax Two-Stage Designs with Applications to Tissue Banking Case-Control Studies, Statistics in Medicine 21 : 2479 – 2493 .
   PubMed Web of Science ®Google Scholar
• Shuster , J. J. , Chang , M. N. , and Tian , L. ( 2004 ). Design of Group Sequential Clinical Trials with Ordinal Categorical Data Based on the Mann-Whitney-Wilcoxon Tests, Sequential Analysis 23 : 414 – 426 .
   Google Scholar
• Simon , R. ( 1991 ). A Decade of Progress in Statistical Methodology for Clinical Trials, Statistics in Medicine 10 : 1789 – 1817 .
   PubMed Web of Science ®Google Scholar
• Souhami , R. L. ( 1994 ). The Clinical Importance of Early Stopping of Randomized Trials in Cancer Treatments, Statistics in Medicine 13 : 1293 – 1295 .
   PubMed Web of Science ®Google Scholar
• Therneau , T. M. , Wieand , H. S. , and Chang , M. N. ( 1990 ). Optimal Designs for a Group Sequential Binomial Trial, Biometrics 46 : 771 – 781 .
   Web of Science ®Google Scholar
• Tsiatis , A. A. ( 1981 ). The Asymptotic Joint Distribution of the Efficient Scores Test for the Proportional Hazards Model Calculated Over Time, Biometrika 68 : 311 – 315 .
   Web of Science ®Google Scholar
• Recommended by Uttam Bandyopadhyay
   Google Scholar